POET Technologies: Disrupting the Multi-Billion Dollar Photonics Market

POET Technologies has always been focused on the disruptive potential of its technology. The Company has created the first-ever wafer-level integratio …

POET Technologies

Faster and cheaper data communications

POET Technologies has always been focused on the disruptive potential of its technology. The Company has created the first-ever wafer-level integration of electronics and photonics into a single device  –  the POET Optical Interposer.

Further, all fabrication, assembly, alignment, testing, burn-in and packaging are done at wafer-level. The POET Optical Interposer then achieves the lowest cost of integrating electronics and photonics, with unparalleled scalability.

Moreover, the POET Optical Interposer is a platform technology providing maximum flexibility and scalability. Both electronic and photonic devices are fabricated into the layers of the Optical Interposer at wafer-level, eliminating active alignment and allowing high-speed communication among all devices. Substituting devices or changing form factors is done with minimal design changes to the platform allowing Optical Interposer-based solutions to span multiple product generations and a wide variety of applications.

The POET Optical Interposer is fabricated in a wafer-level process that is completely compatible with standard CMOS semiconductor processing, making it the solution to a long-sought-after means to co-packaged optics – building photonics communications capability directly into a chip – for high speed computing and networking applications.

For more information on POET Technologies Inc. (TSX.V: PTK, OTCQX: POETF) please fill out the form below.

You might also like

Atlas Salt: Domestic Road Salt Supply Project Advances
February 20, 2026

Atlas Salt: Domestic Road Salt Supply Project Advances

This is some text inside of a div block.
Atlas Salt: Newfoundland De-icing Supply Project Nears Construction
February 20, 2026

CEO Clips - Atlas Salt: Newfoundland De-icing Supply Project Nears Construction

This is some text inside of a div block.
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability
Life Sciences
February 19, 2026

Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability

Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.

This is some text inside of a div block.
Subscribe and receive the investor Info